RemiFemin
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline's mass market launch of black cohosh supplement includes campaign offering women "freedom kit" with coupons, menopause symptom-tracking journal and quarterly health magazine. GSK also is partnering with Cedars-Sinai Integrative Medicine Medical Group and SusanLoveMd.com in an educational program that kicks off this month with a three-part Web chat series on women's health, menopause and herbals. GSK obtained North American marketing rights from German herbals firm Schaper & Brummer; RemiFemin has been sold for the past four years in U.S. health food stores by Enzymatic Therapy. Product is available in 60- and 120-counts, carrying SRPs of $20 and $35.29. TV spots, print ads in women's magazines broke in February; agency is Creative Advertising Solutions (New York)